retatrutide peptide eli lilly ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Lilly's Retatrutide: Toward the End

While Ozempic and other weight-loss drugs have been shown to have myriad benefits, they can also present some unwelcome effects, primarily nausea, vomiting and other gastrointestinal symptoms

BrunPCastagliuoloIDi LeoVBudaAPinzaniMPaluGet al

This product is designated FOR RESEARCH USE ONLY (RUO)

Ferroptosis in sepsis-induced (She et al., 2021) contributes to vascular damage by disrupting the endothelial barrier, increasing vascular permeability, and promoting tissue edema

Concomitant diseases included heart failure (23%), hypertension (91%), previous ischemic stroke (12%), previous MI (40%), and peripheral artery disease (16%)